Celtaxsys Cystic Fibrosis Drug Reduces Key Symptom in Mid-Stage Study Celtaxsys Cystic Fibrosis Drug Reduces Key Symptom in Mid-Stage Study

Privately held Celtaxsys Inc said on Thursday a mid-stage trial testing its experimental cystic fibrosis treatment was successful in reducing a key symptom of the genetic lung disease, but did not improve lung function.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news